2273 Research Boulevard
Rockville, MD 20850
NeuroCytonix Inc., our corporate headquarters, is in Rockville, Maryland USA, based near the US National Institutes of Health (NIH) at Research Boulevard within the Maryland Biotech corridor. Our company's executive management and key staff operate out of this center.
NeuroCytonix Mexico, S.A. DE C.V.
Monterrey Nuevo León, México C.P 64460
NeuroCytonix Mexico was established in 2018 at Monterrey, the capital city of the state of Nuevo Leon, Mexico. The city is set in the spectacular Sierra Madre, mountain region of northwest Mexico.
Our state-of-the-art clinical center at Monterrey is designed in compliance with the FDA rules of “Good Clinical Practice” (GCP). It is strategically located at ‘The Center for Research and Development’ in Health Sciences at the Universidad Autónoma de Nuevo León an institution that provides academic and research infrastructure in the fields of health and biomedicine. Dr. Trujillo was instrumental in creating this center, where he has trained and directed an outstanding clinical research team who currently overseeing FDA trials.
The first FDA-supervised, double-blind, randomized, placebo-controlled clinical trial for fifty children with cerebral palsy was successfully conducted at our Mexico Center. Our clinical center is spread across two floors and is well equipped and designed to manage patients who require specialized care.
Our team of specialists at the Mexico center includes neurologists, doctors, radiologists, nurses, technicians, advisors, and an FDA-experienced regulatory team to conduct FDA-controlled clinical trials.